Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MCS-5

Home DrugsMCS-5

MCS-5

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Nucleic acid sequence segment for enhancing protein expression
Applicant: UNIV CHINA MEDICALPriority: 2015
US
Nucleic acid vector
Applicant: DING ENYUPriority: 2016
US
Method for inhibiting proliferation of extracellular matrix of diabetic nephropathy by kidney maintaining pills
Applicant: MA BAOHUAPriority: 2017
CN
Dual target CAR-T therapy vector for lung cancer and construction method and application of dual target CAR-T therapy vector
Applicant: SHANGHAI YIHAO BIOTECHNOLOGY CO LTDPriority: 2018
CN
Dual-target CAR-T therapeutic vector for breast cancer and construction method and application thereof
Applicant: SHANGHAI YIHAO BIOTECHNOLOGY CO LTDPriority: 2018
CN
Double-target CAR-T therapy vector for liver cancer, as well as construction method and application thereof
Applicant: SHANGHAI YIHAO BIOTECHNOLOGY CO LTDPriority: 2018
CN
Double-target-point CAR-T (Chimeric Antigen Receptor T) treatment vector for gastric cancer, construction method and application thereof
Applicant: SHANGHAI YIHAO BIOTECHNOLOGY CO LTDPriority: 2018
CN
Double-target CAR-T therapy vector for colon cancer, and construction method and application of double-target CAR-T therapy vector
Applicant: SHANGHAI YIHAO BIOTECHNOLOGY CO LTDPriority: 2018
CN
一种人-15-羟基前列腺素脱氢酶过表达质粒的构建方法及其应用
Applicant: 南京医科大学Priority: 2018
CN
AQP5重组过表达载体及其构建方法和用途
Applicant: 汉恒生物科技（上海）有限公司Priority: 2018
CN

Page 1 of 2